glp-1 ra medications More good news related to medications: decrease in substance use and substance use related complications. From BMJ 2026; 392 doi: https://doi.org/10.1136/bmj-2025-086886 (Published 04 March 2026) #onerootmanyrisks #oneminuteforyourhealth Could GLP-1 Receptor Agonists Help

It creates a concentration of 2.5 mg/mL where common doses land on clean, easy-to-read syringe markings

Now there are designer drugs that seem to accomplish the task: we can lose weight without effort using mono, dual, and triple agonists of receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon

This process unveils brighter skin with improved and radiant skin tone

Combined use may represent a more optimal strategy (Tsuriya et al., 2025

10.1016/j.biopha.2022.113601 114

These off-target interactions help explain some of the peptides secondary effects , such as libido enhancement and appetite suppression